June 10, 2020 / 12:56 PM / a month ago

BRIEF-Neurotrope Announces Strategic Partnership With BryoLogyx

June 10 (Reuters) - Neurotrope Inc:

* NEUROTROPE ANNOUNCES STRATEGIC PARTNERSHIP WITH BRYOLOGYX FOR SUPPLY OF SYNTHETIC BRYOSTATIN-1 AND CONTINUATION OF THE NATIONAL CANCER INSTITUTE (NCI) TRIAL FOR CHILDHOOD LEUKEMIA

* NEUROTROPE - UNDER TERMS, BRYOLOGYX WILL SUPPLY CO WITH SPECIFIED AMOUNTS OF SYNTHETIC, GMP-GRADE BRYOSTATIN-1., MANUFACTURED BY AMRI GROUP

* NEUROTROPE - BRYOLOGYX WILL PAY FEE ON GROSS REVENUES GENERATED BY COMMERCIAL SALE OF BRYOSTATIN-1 PRODUCT SOLD BY BRYOLOGYX Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below